AT

Alphatec Holdings IncNASDAQ ATEC Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

0.836

Micro

Exchange

XNAS - Nasdaq

ATEC Stock Analysis

AT

Uncovered

Alphatec Holdings Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-37/100

Low score

Alphatec Holdings, Inc. is a medical technology company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spinal disorders. The Company, through its wholly owned subsidiaries, Alphatec Spine, Inc., SafeOp Surgical, Inc. and EOS imaging S.A. is focused on developing approaches that integrate with its Alpha InformatiX product platform. It has a range of product portfolios designed to address the spine's various pathologies. Its product portfolio includes Alpha InformatiX, which include SafeOp Neural InformatiX System; Access Systems, which include Sigma-TLIF Pedicle-based Access System, PTP Patient Positioning System, and Squadron Lateral Retractor; Fixation Systems, which include InVictus Spinal Fixation Systems (Open and MIS), InVictus MIS SingleStep System, and InVictus Modular Fixation Systems (Open and MIS) and Interbody Systems, which include IdentiTi Porous Ti Interbody Implants and Transcend Lateral Interbody Implants.

View Section: Eyestock Rating